|
Index of reports
> Cases with Atrial Septal Defect (75)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lamotrigine where reactions include atrial septal defect. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 75 Next >>
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-24
Patient: female, weighing 3.5 kg (7.7 pounds)
Reactions: Atrial Septal Defect, Dysmorphism, Neonatal Respiratory Distress Syndrome, Maternal Exposure During Pregnancy, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folic Acid
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-24
Patient: female, weighing 3.5 kg (7.7 pounds)
Reactions: Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Dysmorphism, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Folic Acid
Dosage: 5 mg, daily
Indication: Prophylaxis of Neural Tube Defect
Lamotrigine
Dosage: 500 mg/daily; 275 mg/daily during 1st trimester
Indication: Epilepsy
End date: 2011-02-12
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-24
Patient: female, weighing 3.5 kg (7.7 pounds)
Reactions: Atrial Septal Defect, Dysmorphism, Neonatal Respiratory Distress Syndrome, Maternal Exposure During Pregnancy, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folic Acid
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-07-23
Patient: female, weighing 3.5 kg (7.7 pounds)
Reactions: Atrial Septal Defect, Movement Disorder, Retrognathia, Maternal Drugs Affecting Foetus, Neonatal Respiratory Distress Syndrome, Dysmorphism, Congenital Hand Malformation, Cyanosis Neonatal, Limb Malformation, Bradycardia Neonatal, Congenital Pyelocaliectasis, Congenital Eyelid Malformation, Talipes, Pelvi-Ureteric Obstruction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folsaure (Folic Acid)
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-07-18
Patient: female
Reactions: Atrial Septal Defect, Dysmorphism, Neonatal Respiratory Distress Syndrome, Bradycardia Neonatal, Cyanosis, Respiratory Arrest, Talipes, Congenital Ureteric Anomaly
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folic Acid
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-07-18
Patient: female
Reactions: Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Dysmorphism, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folsaure
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-13
Patient: female, weighing 3.5 kg (7.7 pounds)
Reactions: Movement Disorder, Retrognathia, Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Maternal Drugs Affecting Foetus, Dysmorphism, Ultrasound Scan Abnormal, Cyanosis Neonatal, Bradycardia Neonatal, Congenital Eyelid Malformation, Congenital Anomaly, Talipes, Pyelocaliectasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Dosage: 275 mg, during first trimester, transplacental; 500 mg, precon and throughout pregnancy, transplacen
Indication: Product Used FOR Unknown Indication
End date: 2011-02-12
Lamotrigine
Dosage: 275 mg, during first trimester, transplacental; 500 mg, precon and throughout pregnancy, transplacen
Indication: Product Used FOR Unknown Indication
End date: 2011-02-12
Other drugs received by patient: Folsaure (Folic Acid)
Possible Lamotrigine side effects in
Reported by a physician from Germany on 2012-07-11
Patient:
Reactions: Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Dysmorphism, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folic Acid
Possible Lamotrigine side effects in
Reported by a individual with unspecified qualification from Germany on 2012-07-05
Patient: , weighing 3.2 kg (7.2 pounds)
Reactions: Atrial Septal Defect, Caesarean Section, Maternal Drugs Affecting Foetus, Ventricular Septal Defect, Cephalo-Pelvic Disproportion
Drug(s) suspected as cause:
Clonazepam
Dosage: 0.5 mg, unk, transplacental
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Lamotrigine
Dosage: 75 mg, unk, transplacental
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium (Thyroxin)
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-03
Patient: female, weighing 3.5 kg (7.7 pounds)
Reactions: Atrial Septal Defect, Retrognathia, Neonatal Respiratory Distress Syndrome, Maternal Drugs Affecting Foetus, Dysmorphism, Premature Baby, Cyanosis Neonatal, Bradycardia Neonatal, Eyelid Disorder, Talipes, Congenital Ureteric Anomaly, Pelvi-Ureteric Obstruction, Pyelocaliectasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folic Acid (Folsaure)
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27
Patient: female, weighing 3.2 kg (7.2 pounds)
Reactions: Atrial Septal Defect, Maternal Exposure During Pregnancy, Ventricular Septal Defect
Drug(s) suspected as cause:
Lamotrigine
Dosage: 0.5 [mg/d ]
Start date: 2011-04-14
End date: 2012-01-06
Clonazepam
Dosage: 75 [mg/d ]
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27
Patient: female, weighing 3.2 kg (7.2 pounds)
Reactions: Atrial Septal Defect, Maternal Exposure During Pregnancy, Ventricular Septal Defect
Drug(s) suspected as cause:
Lamotrigine
Dosage: 0.5 [mg/d ]
Start date: 2011-04-14
End date: 2012-01-06
Clonazepam
Dosage: 75 [mg/d ]
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27
Patient: female, weighing 3.2 kg (7.2 pounds)
Reactions: Atrial Septal Defect, Ventricular Septal Defect
Drug(s) suspected as cause:
Lamotrigine
Dosage: 75 [mg/d ]
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Clonazepam
Dosage: 0.5 [mg/d]
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26
Patient: female, weighing 3.3 kg (7.3 pounds)
Reactions: Atrial Septal Defect, Foetal Exposure During Pregnancy, Ventricular Septal Defect, Cephalo-Pelvic Disproportion
Drug(s) suspected as cause:
Clonazepam
Dosage: .5mg per day
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Lamotrigine
Dosage: 75mg per day
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-06-26
Patient: female
Reactions: Atrial Septal Defect, Ventricular Septal Defect
Drug(s) suspected as cause:
Clonazepam
Lamotrigine
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-06-21
Patient: female, weighing 3.2 kg (7.2 pounds)
Reactions: Atrial Septal Defect, Caesarean Section, Maternal Drugs Affecting Foetus, Ventricular Septal Defect, Cephalo-Pelvic Disproportion
Drug(s) suspected as cause:
Clonazepam
Dosage: (0.5 mg, 1 d), transplacental
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Lamotrigine
Dosage: (75 mg, 1 d), transplacental
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-18
Patient: female, weighing 3.2 kg (7.2 pounds)
Reactions: Atrial Septal Defect, Caesarean Section, Maternal Drugs Affecting Foetus, Congenital Anomaly, Ventricular Septal Defect, Cephalo-Pelvic Disproportion
Drug(s) suspected as cause:
Lamotrigine
Dosage: 75 mg, 1 in 1 d, transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2011-04-14
End date: 2012-01-06
Clonazepam
Dosage: 0.5 mg, 1 in 1 d, transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in 26 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-18
Patient: 26 year old female
Reactions: Atrial Septal Defect, Caesarean Section, Ventricular Septal Defect, Cephalo-Pelvic Disproportion
Drug(s) suspected as cause:
Clonazepam
Dosage: 0.5 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Lamotrigine
Dosage: 75 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Epilepsy
Start date: 2011-04-14
End date: 2012-01-06
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-14
Patient:
Reactions: Atrial Septal Defect, Foetal Exposure During Pregnancy, Ventricular Septal Defect
Drug(s) suspected as cause:
Lamotrigine
Dosage: maternal dose: 75 mg/d until 38.1 gw
Antelepsin
Dosage: maternal dose: 0.5 mg/d until 38.1 gw
Other drugs received by patient: Levothyroxine Sodium
Possible Lamotrigine side effects in
Reported by a physician from United Kingdom on 2012-06-13
Patient:
Reactions: Atrial Septal Defect, Dysmorphism, Foetal Exposure During Pregnancy, Patent Ductus Arteriosus
Drug(s) suspected as cause:
Levetiracetam
Lamotrigine
Valproate Sodium
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-06-04
Patient: female, weighing 2.8 kg (6.1 pounds)
Reactions: Atrial Septal Defect, Small FOR Dates Baby, Ventricular Septal Defect, Congenital Cystic Kidney Disease, Congenital Arterial Malformation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clobazam
Start date: 2011-07-18
Carbamazepine
Indication: Foetal Exposure During Pregnancy
Start date: 2011-06-08
End date: 2011-10-13
Lamotrigine
Start date: 2011-03-29
Topiramate
Indication: Foetal Exposure During Pregnancy
Start date: 2011-01-11
End date: 2011-10-13
Valproic Acid
Indication: Foetal Exposure During Pregnancy
Start date: 2011-01-11
End date: 2011-03-29
Levothyroxine Sodium
Indication: Foetal Exposure During Pregnancy
Start date: 2011-01-11
End date: 2011-10-13
Lamotrigine
Indication: Foetal Exposure During Pregnancy
End date: 2011-05-25
Clobazam
Indication: Foetal Exposure During Pregnancy
End date: 2011-10-13
Clobazam
Start date: 2011-03-29
Folic Acid
Indication: Foetal Exposure During Pregnancy
Start date: 2011-03-29
End date: 2011-06-07
Possible Lamotrigine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17
Patient:
Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus
Drug(s) suspected as cause:
Carbamazepine
Dosage: transplacentary
Indication: Epilepsy
Lamotrigine
Dosage: 400 mg/transplacentary
Indication: Epilepsy
Possible Lamotrigine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17
Patient:
Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Syndactyly, Patent Ductus Arteriosus, Congenital Anomaly, Meningomyelocele
Drug(s) suspected as cause:
Valproic Acid
Dosage: 3000 mg / transplacentary
Indication: Epilepsy
Lamotrigine
Dosage: 100 mg/ transplacentary
Indication: Epilepsy
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-02
Patient: female, weighing 3.4 kg (7.5 pounds)
Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Maternal Drugs Affecting Foetus
Drug(s) suspected as cause:
Lamotrigine
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-01
Patient: female, weighing 3.4 kg (7.5 pounds)
Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Maternal Exposure During Pregnancy
Drug(s) suspected as cause:
Lamotrigine
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-01
Patient: female, weighing 3.4 kg (7.5 pounds)
Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Maternal Exposure During Pregnancy
Drug(s) suspected as cause:
Lamotrigine
Possible Lamotrigine side effects in female
Reported by a physician from Germany on 2012-04-30
Patient: female, weighing 3.4 kg (7.5 pounds)
Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Lamotrigine
Possible Lamotrigine side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-24
Patient: female, weighing 3.4 kg (7.5 pounds)
Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Bicuspid Aortic Valve, Congenital Anomaly
Drug(s) suspected as cause:
Lamotrigine
Possible Lamotrigine side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-03
Patient: male, weighing 3.6 kg (7.9 pounds)
Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Hyperbilirubinaemia, Bradycardia Neonatal
Drug(s) suspected as cause:
Lamotrigine
Dosage: 700 mg/d (225-225-250) for two years, transplacental
Indication: Epilepsy
Start date: 2009-11-11
End date: 2010-08-11
Vimpat
Dosage: 200 mg/d (100-0-100) for one year (unknown), transplacental
Indication: Epilepsy
Start date: 2009-11-11
End date: 2010-08-11
Other drugs received by patient: Folic Acid (Folsaure)
Possible Lamotrigine side effects in male
Reported by a consumer/non-health professional from Germany on 2012-04-03
Patient: male, weighing 3.3 kg (7.3 pounds)
Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Caesarean Section, Ventricular Septal Defect
Drug(s) suspected as cause:
Lamotrigine
Other drugs received by patient: Folic Acid (Folsan)
Page 1 Next >>
|
